Preventing adverse outcomes in ART-related twin pregnancies using aspirin

The effectiveness of low-dose aspirin (LDA) in reducing adverse pregnancy outcomes

Cybin to Present 12-Month Phase 2 Data for CYB003 in Major Depressive Disorder on November 18, 2024 | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry platform company committed to revolutionizing mental healthcare by developing new and innovative

November 14, 2024

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO) – Biotech Investments

EQS-News: ABIVAX / Key word(s): Conference Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th

February 14, 2024

Chinese authority approves Medivir’s patent application for fostrox

Medivir’s fostrox is being developed to treat patients with hepatocellular carcinoma, the most common cancer that arises in the liver. Credit: crystal light via shutterstock.com.

June 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.